Back to Search Start Over

Regulation of zeolite-derived upconversion photocatalytic system for near infrared light/ultrasound dual-triggered multimodal melanoma therapy under a boosted hypoxia relief tumor microenvironment via autophagy.

Authors :
Zhang, Yule
Kang, Shifei
Lin, Hui
Chen, Mengya
Li, Yuhao
Cui, Lifeng
Fan, Yan
Wang, Bo
Wang, Yuwen
Yang, Zhijin
Zhao, Mantong
Yin, Xiaomeng
Sun, Di
Dai, Bo
Zhuang, Songlin
Zhang, Dawei
Zheng, Lulu
Source :
Chemical Engineering Journal. Feb2022, Vol. 429, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

[Display omitted] • LTA zeolites loaded C 3 N 4 system could enhance ROS production efficiency via photocatalytic. • C 3 N 4 contributes to high surface conductivity and high drug loading. • UCNPs-C 3 N 4 -Ce6 system could relief the tumour hypoxia. • UCNPs-C 3 N 4 -Ce6 system could induce autophagic cell death with minimal negative side effects. • PDT and SDT was proved capable of maximizing the ROS yield. Reactive oxygen species (ROS) production efficiency, tumor microenvironment hypoxia relief, and autophagy-induced cell death with minimal negative effects are considered the main objectives to achieve more efficient tumor treatment. However, realizing highly effective cancer treatment under hypoxia relief with a cell autophagy model based on suitable biomaterials is still a challenge. Herein, a biosafe upconversion nanomaterial based on Linde Type A (LTA) zeolites loaded with carbon nitride (C 3 N 4) photocatalyst and chlorin e6 (Ce6) was developed as a rationally regulated photocatalytic system and multimodal tumor therapeutic platform. C 3 N 4 contributes to stability, tumor hypoxia relief, high surface conductivity and high drug-loading. Remarkably, photodynamic therapy (PDT) and sonodynamic therapy (SDT) were proven capable of maximizing the ROS yield to obtain highly tumor therapeutic outcomes. Photothermal conversion efficiency was 46.72%. Furthermore, internalized nanomaterials can result in tumor inhibition through cell autophagy. The as-developed system shows a promising potential in the multimodal cancer therapeutics. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13858947
Volume :
429
Database :
Academic Search Index
Journal :
Chemical Engineering Journal
Publication Type :
Academic Journal
Accession number :
153706277
Full Text :
https://doi.org/10.1016/j.cej.2021.132484